comprehensive -WSS

comprehensive

author：focus 2025-09-03 12:08:58 - browse：84

light shines behind Pfizer CEO Albert Bourla as he attends a ceremony in Greece — Pfizer CEO Albert Bourla was one of a few pharmaceutical executives who donated to a failed Senate campaign in New Jersey. Giannis Papanikos/AP

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Administration infighting over the national stockpile

The health department’s preparedness office overseeing national stockpiles of emergency medical gear is trying to cement its Covid-era power — and meeting with congressional skepticism.

The Administration for Strategic Preparedness and Response has seen demands for protective gear and therapies rapidly expand between the Covid-19 pandemic, the 2022 mpox outbreak, and now the spread of avian flu among cows. But its management of the nation’s medical stockpile — and its efforts to replenish depleting stock — are under fresh scrutiny from lawmakers. In particular, Republicans want answers on the $850 million that Congress clawed back from ASPR’s budget, and on why that cash wasn’t spent if the stockpile needed it so badly, my co-author Sarah Owermohle reports.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： STAT Summit: How researchers deal with rejection

focus

WSS

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Roivant's CEO is a star, but biotech's black hole persists

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Health tech investors get more selective as pandemic boom fades

After decades in use, heart stents finally beat placebo

STAT Summit: How researchers deal with rejection

hotspot

comprehensive

Administration infighting over the national stockpile

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

How to save PrEP access — and even expand it

Health tech investors get more selective as pandemic boom fades

New air purifier tech could be key to improving indoor air quality

Cancer diagnosis changes perspective doctor, former hospital CEO

At least 13 dead in Texas as scorching temps continue

Results on Novartis prostate cancer therapy could expand its use

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Affirmative action in medical school literally saved lives

STAT Summit: Meghan O’Rourke on making chronic illness visible

entertainment

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Readout Newsletter: Zepbound, Valneva's vaccine, and more

Type 2 diabetes prevention programs work at large scale: study

Healthy food access boosts outcomes in two studies

Smaller biotechs seek to piggyback on weight loss drug boom

Ohio still needs to do more to protect the right to abortion

explore

entertainment

focus

explore